Intracellular events in platelet activation induced by antiphospholipid antibodies in the presence of low doses of thrombin

Arthritis and Rheumatism

Volumn 50, Issue 9, 2004, Pages 2911-2919

  Vega Ostertag, Mariano ^a   Harris, E Nigel ^a   Pierangeli, Silvia S ^a  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CYTOSOLIC PHOSPHOLIPASE A2; IMMUNOGLOBULIN F(AB')2 FRAGMENT; IMMUNOGLOBULIN G; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHOLIPASE A2; PHOSPHOLIPID ANTIBODY; THROMBIN; THROMBOXANE B2; UNCLASSIFIED DRUG;

ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CELL LYSATE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LOW DRUG DOSE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTOPENIA; THROMBOSIS;

ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; BLOOD PLATELETS; CALCIUM; HEMOSTATICS; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; IMMUNOGLOBULIN G; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHOLIPASES A; PHOSPHORYLATION; PLATELET ACTIVATION; THROMBIN; THROMBOXANE B2;

EID: 4444273214     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.20434     Document Type: Article

References (40)

1. Harris EN, Asherson RA, Gharavi AE, Morgan SH, Derue G, Hughes GR. Thrombocytopenia in SLE and related autoimmune disorders: association with anti-cardiolipin antibody. Br J Haematol 1985;59:227-30.
2. Khamashta MA, Harris EN, Gharavi AE, Derue G, Gil A, Vazquez JJ, et al. Immune mediated mechanism for thrombosis: antiphospholipid antibody binding to platelet membranes. Ann Rheum Dis 1988;47:849-54.
3. Out HJ, deGroot P, van Vliet M, de Gast G, Nieuwenhuis K, Derksen RH. Antibodies to platelets in patients with antiphospholipid antibodies. Blood 1991:77:2655-9.
4. Shatter Y, Tall Y, Greenberg A, Brenner B. Platelet activation in patients with antiphospholipid syndrome. Blood Coag Fibrinol 1998;9:653-7.
5. Hasselaar P, Derksen RH, Blokzijl L, deGroot PG. Crossreactivity of antibodies directed against cardiolipin, DNA, endothelial cells and blood platelets. J Thromb Haemost 1990;63:169-73.
6. Lellouche F, Martinuzzo M, Said P, Maclouf J, Carreras LO. Imbalance of thromboxane/prostacyclin biosynthesis in patients with lupus anticoagulant. Blood 1991;78:2894-9.
7. Campbell A, Pierangeli SS, Wellhausen S, Harris EN. Comparison of the effects of anticardiolipin antibodies from patients with the antiphospholipid syndrome and with syphilis on platelet activation and aggregation. J Thromb Haemost 1995;73:529-34.
8. Espinola RG, Pierangeli SS, Gharavi AE, Harris EN. Hydroxychloroquine reverses platelet activation induced by human IgG antiphospholipid antibodies. J Thromb Haemost 2002;87:518-22.
9. Ling YL, Wang CT. Activation of human platelets by the rabbit anticardiolipin antibodies. Blood 1992;80:3135-43.
10. 2 glycoprotein I complexes on production of thromboxane A2 by platelets from patients with the antiphospholipid syndrome. J Rheumatol 1998;25:51-6.
11. Buschbeck M, Ghomashchi F, Gelb MH, Watson SP, Borsch-Haubold AG. Stress stimuli increase calcium-induced arachidonic acid release through phosphorylation of cytosolic phospholipase A2. Biochemistry 1999;344:359-66.
12. Borsch-Haubold AG, Ghomashchi F, Pasquet S, Goedert M, Cohen P, Gelb MH, et al. Phosphorylation of cytosolic phospholipase A2 in platelets is mediated by multiple stress-activated protein kinase pathways. Eur J Biochem 1999;265:195-203.
13. Nadal-Wollbold F, Pawlowski M, Levy-Toledano S, Berrou E, Rosa JP, Brycjaert M. Platelet ERK2 activation by thrombin is dependent on calcium and conventional protein kinases C but not Raf-1 or B-Raf. FEBS Lett 2002;531:475-82.
14. Levy-Toledano S, Gallet C, Nadal F, Bryckaert M, Maclouf J, Rosa J-P. Phosphorylation and dephosphorylation mechanisms in platelet function: a tightly regulated balance. J Thromb Haemost 1997;78:226-33.
15. Levy-Toledano S. Platelet signal transduction pathways: could we organize them into a "hierarchy"? Haemostasis 1999:29:4-15.
16. Wang L, Su CY, Chou KY, Wang CT. Enhancement of human platelet activation by the combination of low concentrations of collagen and rabbit anticardiolipin antibodies. Br J Haematol 2002;118:1152-62.
17. Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999;42;1309-11.
18. Harris EN. Annotation: antiphospholipid antibodies. Br J Haematol 1990;74:1-9.
19. Palomo I, Pereira J, Alarcon M, Larrain AM, Pinochet C, Vasqez M, et al. Antiphospholipid antibodies in Chilean patients with systemic lupus erythematosus. J Lab Clin Med 2002;14:336-41.
20. Exner T, Ricard KA, Kronenberg H. A sensitive test demonstrating lupus anticoagulant and its behavioral patterns. Br J Haematol 1985;59:227-30.
21. Hackeng CM, Relou IA, Pladet MA, Gorter G, van Rijn HJ, Akkerman JW. Early platelet activation by low density lipoprotein via p38MAP kinase. J Thromb Haemost 1999;82:1749-56.
22. Davies SP, Reddy H, Caivano M, Cohen M. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochemistry 2000;351:95-105.
23. Pierangeli SS, Liu X, Barker JH, Anderson G, Harris EN. Induction of thrombosis in a mouse model by IgG, IgM and IgA immunoglobulins from patients with the antiphospholipid syndrome. J Thromb Haemost 1995;74:1361-7.
24. Espinola RG, Liu X, Colden-Stanfield M, Hall J, Harris EN, Pierangeli SS. E-selectin mediates pathogenic effects of antiphospholipid antibodies. J Thromb Haemost 2003;1:843-8.
25. 2lycoprotein I dependent antiphospholipid antibodies in a photochemically induced thrombosis model in the hamster. Blood 2002;101:157-62.
26. Martinuzzo ME, Maclouf J, Carreras LO, Levy-Toledano S. Antiphospholipid antibodies enhance thrombin-induced platelet activation and thromboxane formation. J Thromb Haemost 1993:70;667-71.
27. 2glycoprotein I. J Thromb Haemost 1993;70:336-41.
28. 2 gycoprotein I induced synthesis of human platelet thromboxane A2 in vitro. J Rheumatol 2003;30:55-9.
29. Gonzalez-Buritica H, Khamashta MA, Hughes GR. Is there a role for phospholipases in the anti-cardiolipin syndrome? Clin Exp Rheumatol 1988;6:341-2.
30. 2+. J Biol Chem 1993;268:26796-804.
31. Hefner Y, Borsch-Haubold AG, Murakami M, Wilde JI, Pasquet S, Schielts D, et al. Serine 727 phosphorylation and activation of cytosolic phospholipase A2 by MNK1-related protein kinases. J Biol Chem 2000;275:37542-51.
32. Lin LL, Wartmann M, Lin AY, Knopf JL, Seth A, Davis RJ. cPLA2 is phophorylated and activated by MAP kinase. Cell 1993;72:269-78.
33. Nemenoff RA, Winitz S, Qian NX, Van Putten V, Johnson GL, Heasley LE. Phosphorylation and activation of a high molecular weight form of phospholipase A2 by p42 microtubule-associated protein 2 kinase and protein kinase. J Biol Chem 1993;268:1960-4.
34. Borsch-Haubold AG, Bartoli F, Asselin J, Dudler T, Kramer RM, Apitz-Castro R, et al. Identification of the phosphorylation sites of cytosolic phospholipasse A2 in agonist-stimulated human platelets and HeLA cells. J Biol Chem 1998;273:4449-58.
35. Borsch-Haubold AG, Kramer RM, Watson SP. Cytosolic phospholipase A2 is phosphorylated in collagen- and thrombin-stimulated human platelets independent of protein kinase C and mitogen-activated protein kinase. J Biol Chem 1995;270:25885-98.
36. Saklatvala J, Rawlinson L, Waller RJ, Sarsfield S, Lee JC, Morton LF, et al. Role for p38 mitogen-activated protein kinase in platelet aggregation caused by collagen or a thromboxane analog. J Biol Chem 1996;271:6586-9.
37. Borsch-Haubold AG, Kramer RM, Watson SP. Inhibition of mitogen-activated protein kinase kinase does not impair primary activation of human platelets. Biochemistry 1996;318:207-12.
38. Kramer RM, Roberts EF, Um SL, Borsch-Haubold AG, Watson SP, Fisher MJ, et al. p38 mitogen-activated protein kinase phosphorylates cytosolic phospholipase A2 (cPLA2) in thrombinstimulated platelets: evidence that proline-directed phosphorylation is not required for mobilization of arachidonic acid by cPLA2. J Biol Chem 1996;271:27723-9.
39. Borsch-Haubold AG, Pasquet S, Watson SP. Direct inhibition of cyclooxygenase-1 and -2 by the kinase inhibitors SB203580 and PD98059. J Biol Chem 1998;273:28766-72.
40. 2-glycoprotein I increase platelet deposition to collagen via interaction with phospholipids and the apolipoprotein E receptor 2. J Biol Chem 2003;278:33831-8.